To the best of our knowledge, this is the first prospective cohort study to show the association of serum total SOD activity and SOD1/2 concentrations with lung cancer prognosis in pretreatment patients, taking into consideration a multifaceted background including clinical stage, comorbidities, and other clinical, biochemical, and sociodemographic data. Here, SOD1 is linked to lung carcinoma.